Asparaginase-Based Treatments in Young and Older Adults With Acute Lymphoblastic Leukemia: Leveraging the Pediatric Experience

Download All
Gain expert insights with an on-demand webcast and downloadable slides from a live symposium at ASH 2021 on the optimal use of pediatric asparaginase-regimens in the treatment of a AYA and adult patients with ALL, including patient case discussions and practical guidance on strategies to support completion of therapy.
Wendy Stock, MD
Program Director
Emily Curran, MD
Dan Douer, MD
person default
Scott Howard, MD, MSc
person default
Stephen P. Hunger, MD

Downloadable Slidesets

Download this slideset from a live CCO symposium for an expert overview on applying pediatric ALL regimens to the treatment of AYA and adult patients with ALL.

Wendy Stock, MD
Program Director
Released: December 15, 2021

Download this slideset from a live CCO symposium for an expert overview of considerations regarding the use of asparaginase in the treatment of ALL, including discussion of available formulations and optimal management of hypersensitivity reactions.

person default Stephen P. Hunger, MD Released: December 15, 2021

Download this slideset from a live CCO symposium for an expert overview on identifying and managing adverse events associated with asparaginase-based therapy in patients with ALL, including discussion of hepatotoxicity, thrombosis, pancreatitis, hypertriglyceridemia, and factors contributing to their development.

Wendy Stock, MD
Program Director
Emily Curran, MD Dan Douer, MD person default Scott Howard, MD, MSc person default Stephen P. Hunger, MD
Released: December 15, 2021

Download this short summary slideset of key takeaways from a live CCO Webinar on the optimal use of pediatric asparaginase-based regimens in the treatment of a AYA and adult patients with ALL.

Wendy Stock, MD
Program Director
Emily Curran, MD Dan Douer, MD person default Scott Howard, MD, MSc person default Stephen P. Hunger, MD
Released: December 20, 2021

On Demand Webcast

Watch this on-demand webcast of a live CCO webinar where an expert panel discusses the optimal use of pediatric asparaginase regimens in the treatment of AYA and adult patients with ALL, including patient case discussions and practical guidance on strategies to support completion of therapy.

Wendy Stock, MD
Program Director
Emily Curran, MD Dan Douer, MD person default Scott Howard, MD, MSc person default Stephen P. Hunger, MD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: January 24, 2022 Expired: January 23, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Jazz Pharmaceuticals
Servier Pharmaceuticals
Servier Oncology Global Medical and Patient Affairs

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings